Previous 10 | Next 10 |
Stock market indices stand to finish mixed after a holiday-shortened week where Congressional hearings around GameStop (GME) dominated headlines. The Nasdaq (COMP) may eke out a small gain for the week, while the S&P 500 (SP500) is down about 0.8% at the time of this writing. Dow Industri...
Quidel Corporation ([[QDEL]] -10.9%) has failed to meet the consensus revenue estimates in Q4 2020 despite the surging pandemic driving a ~80.6% YoY sequential growth in revenue from COVID-19 products.Today, the stock is leading a broader selloff among COVID-19 test makers after Evercore ISI ...
The following slide deck was published by Fluidigm Corporation in conjunction with their 2020 Q4 earnings call. For further details see: Fluidigm Corporation 2020 Q4 - Results - Earnings Call Presentation
Shares of Fluidigm (NASDAQ: FLDM) were sinking 18.1% lower as of 11:28 a.m. EST on Thurday. The big decline came after the biotechnology tools provider announced its fourth-quarter results following the market close on Wednesday. Fluidigm reported that its revenue in the fourth ...
Anchiano Therapeutics (ANCN) -28%.Pulmatrix (PULM) -21% on direct offering.United States Antimony (UAMY) -21% on direct offering.Cancer Genetics (CGIX) -21% on stock offering.BioHiTech Global (BHTG) -15%.Fluidigm (FLDM) -14% on Q4 earnings; inks distrib...
Fluidigm Corporation (FLDM) Q4 2020 Earnings Conference Call February 10, 2021 5:00 PM ET Company Participants Agnes Lee - Vice President, Investor Relations Chris Linthwaite - President and Chief Executive Officer Vikram Jog - Chief Financial Officer Conference Call Participants Sung Nam - B...
Fluidigm (FLDM) announces a supply and distribution agreement with contract research organization Zhejiang PuLuoTing Health Technology to market Fluidigm CyTOF technology, panels and reagents to clinical labs in China.As part of the agreement, the companies are collab...
Fluidigm (FLDM): Q4 Non-GAAP EPS of -$0.13 misses by $0.14; GAAP EPS of -$0.24 misses by $0.17.Revenue of $44.6M (+37.5% Y/Y) misses by $6.11M.Shares -9%.Press Release For further details see: Fluidigm EPS misses by $0.14, misses on revenue
Fourth Quarter Total Revenue Increased 38 Percent to $44.6 million Fourth Quarter Product and Service Revenue Increased 26 Percent to $40.5 million Full Year Total Revenue Increased 18 Percent to $138.1 million Collaboration with PLT Tech to Market ...
SOUTH SAN FRANCISCO, Calif., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that George Mason University in Fairfax, Va., is provid...
News, Short Squeeze, Breakout and More Instantly...
SOUTH SAN FRANCISCO, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (“Standard BioTools” or the “Company”) (Nasdaq: LAB) today announced that it will report second quarter 2024 financial results on Wednesday, July 31, 2024, after the close of the...
SOUTH SAN FRANCISCO, Calif and SALT LAKE CITY, May 28, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB) today announced that it has purchased the LSA XT system from Carterra ® , a leading provider of high-throughput large and small molecule screening and characteriza...
Ahead of plan on operating expense synergies; $50 million of $80 million target to be achieved by year-end 2024 with remaining balance in FY2025 Delivered pro forma combined revenue of $46.2 million, gross margin of 49.2%, non-GAAP gross margin of 56.3%, operating expense reduction of app...